A woman is told something looks suspicious on her mammogram and a biopsy is ordered. When the biopsy doesn’t find cancer, her sigh can be heard around the world. And while this is good news, she may still need to be concerned.

Good news has been released for women whose cervical cancer has spread, returned or no longer responds to therapy. A drug used for a number of different cancers may help these women live longer.

Lung cancer is the number one cause of cancer-related deaths for both men and women in the United States. For women in Europe, breast cancer is their biggest death threat – but not for long.

Triple-negative breast cancer is so tough to beat because there are few treatment options. Scientists have uncovered more about how triple-negative breast cancer behaves, and these findings could improve the outlook for patients.

What if the odds of beating ovarian cancer could be improved by tinkering with existing chemotherapies? Tweaking chemo regimens may help patients who become resistant to initial therapies.

Being overweight or obese can increase the risk of chronic diseases, including cancer. Breast cancer, in particular, has been associated with carrying too much weight. Scientists have drilled down on this link.

Screening recommendations for breast cancer continue to change. A new study now suggests that older women do not need to be screened as often as younger women. A breast cancer screening expert questions those conclusions.

Surgeons don’t always know what’s going on inside the body until they get in there. With uterine cancer, an old lab technique may help doctors in the middle of the surgery.

Watching television and other passive screen activities have been linked to obesity. The act of being inactive and the time devoted to these in-activities are the issue. So does watching the boob tube impact breast cancer survival?

Modern cancer research continues to show that it’s the genetic mutation at the root of the tumor that must be dealt with to effectively eliminate the cancer. The same is true for aggressive uterine cancer.